某部队破伤风抗体基线水平及持久性调查
该研究检测680名新兵和691名已接种破伤风疫苗的维和人员的破伤风抗体水平。新兵抗体阳性率74.85%,维和人员99.86%;抗体几何平均浓度分别为0.05和0.70 IU/mL。接种一剂破伤风加强针后,保护性抗体水平可持续长达22年。
要点
- 新兵破伤风抗体阳性率较低,建议入伍时筛查抗体。
- 接种一剂加强针后保护性抗体可维持22年,期间无需重复加强。
- 不同省份新兵抗体阳性率差异显著,需精准补种。
核心结论
- 新兵破伤风抗体阳性率较低,需筛查并实施精准加强免疫。
- 接种一剂破伤风疫苗加强针后,保护性抗体水平可持续长达22年。
研究设计与样本
- 选取680名新兵观察破伤风抗体水平。
- 2005至2015年纳入691名已接种破伤风疫苗的维和人员,进行问卷和血清学调查,采用整群分层抽样。
主要发现
- 新兵和维和人员破伤风抗体阳性率分别为74.85%和99.86%(χ2=193.00,P<0.05)。
- 新兵和维和人员抗体几何平均浓度分别为0.05和0.70 IU/mL(t=15.73,P<0.05)。
- 12个省份新兵抗体阳性率从47.62%(湖北)到100%(内蒙古)不等(χ2=37.24,P<0.05),几何平均浓度从0.02(湖北)到0.09 IU/mL(黑龙江)不等(F=5.19,P<0.01)。
- 691名维和人员中,男女抗体阳性率无统计学显著差异。
- 接种一剂破伤风疫苗加强针后,保护性抗体水平可持续长达22年;10年内接种一剂与两剂及以上加强针的抗体水平有显著差异。
临床怎么用
- 征兵时应筛查破伤风抗体,对阳性率较低者实施精准加强免疫。
- 接种一剂破伤风疫苗加强针后,22年内无需重复加强。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine tetanus antibody levels in army recruits and evaluate the persistence of immunity following tetanus booster immunization in adults. METHODS: A total of 680 recruits were selected for observation of their tetanus antibody levels. From 2005 to 2015, 691 peacekeepers with tetanus vaccination were included in the questionnaire-based and serological survey based on cluster stratification. The tetanus antibody-positive rate, geometric mean concentration (GMC), and their respective changes over time were analyzed in different age groups, regions, and years after tetanus booster immunization. RESULTS: The positivity rates of tetanus antibodies in the recruits and peacekeepers were 74.85% and 99.86%, respectively (χ2 = 193.00, P < 0.05) and the antibody GMCs were 0.05 and 0.70 IU/mL (t = 15.73, P < 0.05). The antibody positivity rates of recruits from 12 provinces ranged from 47.62% (Hubei) to 100% (Inner Mongolia) (χ2 = 37.24, P < 0.05) and the antibody GMCs ranged from 0.02 (Hubei) to 0.09 IU/mL (Heilongjiang) (F = 5.19, P < 0.01). Among the 691 peacekeepers, no statistically significant difference in antibody positivity rate was detected between men and women. After administration of one booster dose of the tetanus vaccine, a protective antibody level was calculated to persist up to 22 years; a significant difference in antibody levels was observed within 10 years between one and two or more booster doses. CONCLUSION: The rate at which recruits tested positive for tetanus antibodies was low. Thus, it is necessary to screen for tetanus antibodies during military recruitment and implement a precision-based booster immunization protocol for tetanus vaccine. Moreover, one dose of the tetanus vaccine booster has been calculated to maintain a protective antibody level up to 22 years, without the need for repeated reinforcements during this period.
引用
- Tong L, Jia Q, Li B, et al. Investigation of the baseline tetanus antibody level and its persistence in a military unit. Vaccine. 2021. PMID: 34147291. doi:10.1016/j.vaccine.2021.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。